Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01042392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
January 31, 2011
Enrollment
506 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension